Celgene Corp. buy tamam
Start price
24.08.15
/
50%
€102.94
Target price
28.08.15
€117.40
Performance (%)
7.65%
End price
28.08.15
€110.81
Summary
This prediction ended on 28.08.15 with a price of €110.81. With a performance of 7.65%, the BUY prediction by tamam for Celgene Corp. closed with a slight gain. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celgene Corp. | - | - | - | - |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% | 65.851% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% | 93.298% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% | 89.079% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% | 71.942% |
Comments by tamam for this prediction
In the thread Celgene Corp. diskutieren
tamam stimmt der Outperform-Einschätzung der institutionellen Analysten zu
tamam stimmt am 24.08.2015 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 130.16€ zu.
(Vom Mitglied beendet)


